Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.
2.

Schizophrenia Outpatient Health Outcomes study: twelve-month findings.

Novick D, Ascher-Svanum H, Haro JM, Bertsch J, Takahashi M.

Pragmat Obs Res. 2012 Jun 6;3:27-40. eCollection 2012.

3.

Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

Belvederi Murri M, Guaglianone A, Bugliani M, Calcagno P, Respino M, Serafini G, Innamorati M, Pompili M, Amore M.

Drugs R D. 2015 Mar;15(1):45-62. doi: 10.1007/s40268-014-0078-0. Review.

4.

Clozapine-induced rabbit syndrome: a case report.

Hocaoglu C.

Ment Illn. 2009 Oct 30;1(1):e1. doi: 10.4081/mi.2009.e1. eCollection 2009 Oct 30.

5.

Second-generation antipsychotics and extrapyramidal adverse effects.

Divac N, Prostran M, Jakovcevski I, Cerovac N.

Biomed Res Int. 2014;2014:656370. doi: 10.1155/2014/656370. Epub 2014 Jun 3. Review.

6.

Augmenting amisulpride with clozapine had led to unmasking of akathisia.

Ray A, Munshi S.

Ind Psychiatry J. 2012 Jul;21(2):152-4. doi: 10.4103/0972-6748.119638.

7.
9.

Tardive dyskinesia: treatment with aripiprazole.

Kang NR, Kim MD.

Clin Psychopharmacol Neurosci. 2011 Apr;9(1):1-8. doi: 10.9758/cpn.2011.9.1.1. Epub 2011 Apr 30.

10.

Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.

Coulston CM, Perdices M, Henderson AF, Malhi GS.

Schizophr Res Treatment. 2011;2011:501726. doi: 10.1155/2011/501726. Epub 2010 Jul 27.

11.

Drug-induced parkinsonism.

Shin HW, Chung SJ.

J Clin Neurol. 2012 Mar;8(1):15-21. doi: 10.3988/jcn.2012.8.1.15. Epub 2012 Mar 31.

12.

Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital.

Piparva KG, Parmar DM, Singh AP, Gajera MV, Trivedi HR.

Indian J Psychol Med. 2011 Jan;33(1):54-8. doi: 10.4103/0253-7176.85396.

13.

Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Caroff SN, Hurford I, Lybrand J, Campbell EC.

Neurol Clin. 2011 Feb;29(1):127-48, viii. doi: 10.1016/j.ncl.2010.10.002.

14.

Clozapine: Current perspective.

Solanki RK, Singh P, Swami MK.

Indian J Psychiatry. 2007 Oct;49(4):271-6. doi: 10.4103/0019-5545.37668.

15.
16.

Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Caligiuri MP, Teulings HL, Dean CE, Niculescu AB 3rd, Lohr JB.

Psychiatry Res. 2010 May 15;177(1-2):77-83. doi: 10.1016/j.psychres.2009.07.005. Epub 2010 Apr 9.

17.

A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors.

Jeon J, Dencker D, Wörtwein G, Woldbye DP, Cui Y, Davis AA, Levey AI, Schütz G, Sager TN, Mørk A, Li C, Deng CX, Fink-Jensen A, Wess J.

J Neurosci. 2010 Feb 10;30(6):2396-405. doi: 10.1523/JNEUROSCI.3843-09.2010.

18.

Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.

Choi YK, Moran-Gates T, Gardner MP, Tarazi FI.

Eur Neuropsychopharmacol. 2010 Mar;20(3):187-94. doi: 10.1016/j.euroneuro.2009.09.002. Epub 2009 Oct 29.

19.

Effects of risperidone on glutamate receptor subtypes in developing rat brain.

Choi YK, Gardner MP, Tarazi FI.

Eur Neuropsychopharmacol. 2009 Feb;19(2):77-84. doi: 10.1016/j.euroneuro.2008.08.010. Epub 2008 Oct 9.

20.

Supplemental Content

Support Center